Moderna’s mRNA Access program (Nasdaq: MRNA) enables researchers to use its mRNA technology platform for research projects related to emerging and neglected infectious diseases. “It takes a community of scientists and disease experts to develop novel vaccines to tackle our greatest public health threats,” said Hamilton Bennett, Moderna’s senior director, vaccine access and partnerships. “mRNA Access was…
RCSB Protein Data Bank now has more than 1,000 SARS-CoV-2 proteins
The RCSB Protein Data Bank has announced that more than 1,000 SARS-CoV-2 proteins are available at no cost. Headquartered at Rutgers University–New Brunswick, the RCSB Protein Data Bank released its first SARS-CoV-2 structure — the coronavirus main protease (PDB 6lu7) — on Feb. 5, 2020. The database has helped drive the development of effective COVID-19 vaccines. It continues to shed…